a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical operation and treatment status.</p>b<p><i>P</i> value for heterogeneity.</p>c<p>Other carcinomas include large cell, undifferentiated and mixed-cell carcinomas.</p
<p>CSS, cancer-specific survival. N, data cannot be figured out. SRCC, signet-ring cell carcinoma; P...
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>(a), Survival analysis of subgroups, (b) Rates of driver gene variations of subgroups. NS with AC...
a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical op...
<p>(A) Squamous cell carcinoma group, (B) ever smokers group, (C) ECOG performance status = 1 group...
a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical op...
<p>Univariate analysis of overall survival in NSCLC patients stratified based on clinical characteri...
<p>(A) Squamous cell carcinoma group, (B) ever smokers group, (C) ECOG performance status = 1 group...
<p>Abbreviations: CR, complete response; OR, odds ratio; PD, progressive disease; PR, partial respon...
<p>*Wedge, n = 10.</p><p>Abbreviations: NR = not reached; PS = Performance status; SCC = Squamous ce...
<p>TACE, transcatheter hepatic arterial chemoembolization; HR, hazard ratio; CI, confidence interval...
a<p>In each stratified analysis, HRs were adjusted for age, gender, HBsAg, serum AFP, tumor size, BC...
<p>Abbreviations: MST, median survival time; HR, hazard ratio.</p><p>Note: The frequency of rs156448...
<p>A) 60 patients with NSCLC. B) 31 patients with localized disease (stage I-III). C) 29 patients wi...
<p>Subjects were divided into 2 groups by genetic maker (rs1047781+rs8176746). Group 1 was rs1047781...
<p>CSS, cancer-specific survival. N, data cannot be figured out. SRCC, signet-ring cell carcinoma; P...
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>(a), Survival analysis of subgroups, (b) Rates of driver gene variations of subgroups. NS with AC...
a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical op...
<p>(A) Squamous cell carcinoma group, (B) ever smokers group, (C) ECOG performance status = 1 group...
a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical op...
<p>Univariate analysis of overall survival in NSCLC patients stratified based on clinical characteri...
<p>(A) Squamous cell carcinoma group, (B) ever smokers group, (C) ECOG performance status = 1 group...
<p>Abbreviations: CR, complete response; OR, odds ratio; PD, progressive disease; PR, partial respon...
<p>*Wedge, n = 10.</p><p>Abbreviations: NR = not reached; PS = Performance status; SCC = Squamous ce...
<p>TACE, transcatheter hepatic arterial chemoembolization; HR, hazard ratio; CI, confidence interval...
a<p>In each stratified analysis, HRs were adjusted for age, gender, HBsAg, serum AFP, tumor size, BC...
<p>Abbreviations: MST, median survival time; HR, hazard ratio.</p><p>Note: The frequency of rs156448...
<p>A) 60 patients with NSCLC. B) 31 patients with localized disease (stage I-III). C) 29 patients wi...
<p>Subjects were divided into 2 groups by genetic maker (rs1047781+rs8176746). Group 1 was rs1047781...
<p>CSS, cancer-specific survival. N, data cannot be figured out. SRCC, signet-ring cell carcinoma; P...
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>(a), Survival analysis of subgroups, (b) Rates of driver gene variations of subgroups. NS with AC...